Universe Pharmaceuticals Inc. (UPC) Financials

UPC Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2023 53.3 million 13.8 million
Sept. 30, 2023 53.3 million 13.8 million
June 30, 2023 70.4 million 23.2 million
March 31, 2023 70.4 million 23.2 million

UPC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2023 -3.7 million -984504
Sept. 30, 2023 ? ?
June 30, 2023 4.8 million 5.0 million
March 31, 2023 ? ?

UPC Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2023 -5.4 million
Sept. 30, 2023 -2.7 million
June 30, 2023 -715427
March 31, 2023 -357714

UPC Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2023 18.5 million - -
Sept. 30, 2023 - - -
June 30, 2023 26.3 million - -
March 31, 2023 26.3 million - -

UPC Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2023 3.6 million
Sept. 30, 2023 3.6 million
June 30, 2023 3.6 million
March 31, 2023 3.6 million

UPC Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2023 43523 2.6 million - -
Sept. 30, 2023 - - - -
June 30, 2023 646 2.2 million - -
March 31, 2023 323 - - -

UPC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2023 13.8 million 9.8 million
Sept. 30, 2023 - -
June 30, 2023 18.5 million 12.5 million
March 31, 2023 - -

UPC

Price: $4.24

52 week price:
2.00
17.96

Earnings Per Share: -8.06 USD

P/E Ratio: -0.33

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: China

Volume: 21268

Market Capitalization: 4.0 million

Links: